China Shineway Pharmaceutical
China Shineway Pharmaceutical Holdings Limited, commonly referred to as Shineway, is a prominent player in the pharmaceutical preparation manufacturing industry. Headquartered in China (CN), the company has established a significant presence across various operational regions, focusing on the development and production of high-quality pharmaceutical products.
Founded in 1992, Shineway has achieved notable milestones, including the expansion of its product portfolio and enhancements in manufacturing capabilities. The company is renowned for its core offerings, which include traditional Chinese medicine and modern pharmaceuticals, distinguished by their efficacy and adherence to stringent quality standards.
With a strong market position, Shineway has garnered recognition for its commitment to innovation and excellence, making it a trusted name in the pharmaceutical sector. Its dedication to research and development further solidifies its reputation as a leader in the industry.
-21 vs industry average
China Shineway Pharmaceutical’s score of 17 is lower than 11% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at China Shineway Pharmaceutical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2024
Reported emissions
Scope 3 accounts for ••• of total emissions.
China Shineway Pharmaceutical's reported carbon emissions
China Shineway Pharmaceutical, a company based in China within the Pharmaceutical Preparation Manufacturing industry, has disclosed emissions data for several years.
For the reporting year 2021, China Shineway Pharmaceutical reported total greenhouse gas emissions of approximately 117,794,000 kg CO2e. This total is comprised of Scope 1 emissions totalling approximately 76,087,000 kg CO2e, Scope 2 emissions of approximately 16,885,000 kg CO2e, and Scope 3 emissions of approximately 24,822,000 kg CO2e.
In 2020, the company's total emissions were approximately 130,989,000 kg CO2e, with Scope 1 emissions at approximately 100,252,000 kg CO2e, Scope 2 at approximately 7,391,000 kg CO2e, and Scope 3 at approximately 23,345,000 kg CO2e.
The previous year, 2019, saw total emissions of approximately 145,136,000 kg CO2e, broken down into Scope 1 emissions of approximately 111,082,000 kg CO2e, Scope 2 emissions of approximately 9,492,000 kg CO2e, and Scope 3 emissions of approximately 24,561,000 kg CO2e.
For 2018, the total emissions were approximately 145,465,000 kg CO2e, with Scope 1 emissions at approximately 108,236,000 kg CO2e, Scope 2 emissions at approximately 13,184,000 kg CO2e, and Scope 3 emissions at approximately 24,045,000 kg CO2e.
In 2017, China Shineway Pharmaceutical reported total emissions of approximately 153,410,000 kg CO2e, with Scope 1 emissions at approximately 117,620,000 kg CO2e, Scope 2 emissions at approximately 8,186,000 kg CO2e, and Scope 3 emissions at approximately 27,604,000 kg CO2e.
The company's emissions data is cascaded from its corporate family, with data originating from China Shineway Pharmaceutical Group Limited. Specific reduction targets or commitments such as those from SBTi, CDP, RE100, or Climate Pledge are not detailed in the provided information. Intensity metrics such as GHG intensity per revenue, per fixed assets, and per employee are available for various reporting years. For example, in 2024, GHG intensity per employee was reported as 6,330.0 kg CO2e per employee. In 2022, GHG intensity per employee was 34,220.0 kg CO2e per employee. In 2021, Scope 3 GHG emissions intensity per employee was 6,760.0 kg CO2e per employee.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
China Shineway Pharmaceutical’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for China Shineway Pharmaceutical yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
China Shineway Pharmaceutical
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project